Maser Christina, Donovan Patricia, Santos Florie, Donabedian Richard, Rinder Christine, Scoutt Leslie, Udelsman Robert
Department of Surgery, Yale New Haven Hospital, Yale University School of Medicine, 330 Cedar Street, FMB 102, P.O. Box 208062, New Haven, CT 06520-8062, USA.
Ann Surg Oncol. 2006 Dec;13(12):1690-5. doi: 10.1245/s10434-006-9180-z. Epub 2006 Sep 29.
Persistent or recurrent primary hyperparathyroidism (1 degrees HPTH) is ideally treated with limited dissection, based on accurate localization, to minimize operative risks. To accurately localize parathyroid tissue, we employed ultrasound-guided fine needle aspiration (US FNA) with an on-site rapid parathyroid hormone (PTH) assay to confirm localization.
Of the 272 patients evaluated for 1 degrees HPTH, 34 had persistent or recurrent disease. Standard localization was equivocal in 12, who were referred for US FNA. Suspicious tissue was identified on US and FNA was performed. Analysis with a rapid PTH assay provided on-site result within 12 min. Patients were monitored clinically, and then discharged after observation.
Twelve patients were referred for US FNA; eight were female. Ten patients had persistent disease, one had recurrent, and one had 1 degrees HPTH following thyroidectomy. Two of the 12 were excluded due to negative ultrasound examination. Of the remaining ten, positive aspirates were found in nine, and seven proceeded to surgery. In six patients there was 100% correlation between sonographic and operative findings. The remaining patient had no identifiable adenoma, but PTH normalized after arterial ligation. All patients received a limited directed surgical approach, employing cervical block anesthesia in three. Four were discharged on the day of surgery and all were cured. There was one infectious complication of US FNA.
The use of rapid PTH assay can be effectively utilized for localization of parathyroid tissue in remedial parathyroid surgery. Confirmation of localization markedly improves subsequent surgery and allows selective use of minimally invasive techniques.
持续性或复发性原发性甲状旁腺功能亢进症(1°HPTH)理想的治疗方法是在精确定位的基础上进行有限切除,以将手术风险降至最低。为了精确地定位甲状旁腺组织,我们采用了超声引导下细针穿刺抽吸术(US FNA)并结合现场快速甲状旁腺激素(PTH)检测来确认定位。
在272例接受1°HPTH评估的患者中,34例患有持续性或复发性疾病。12例患者的标准定位不明确,因此被转诊接受US FNA。超声检查发现可疑组织后进行FNA。通过快速PTH检测分析可在12分钟内得出现场结果。对患者进行临床监测,然后在观察后出院。
12例患者被转诊接受US FNA;8例为女性。10例患者患有持续性疾病,1例为复发性疾病,1例在甲状腺切除术后患有1°HPTH。12例患者中有2例因超声检查阴性而被排除。在其余10例患者中,9例穿刺抽吸结果为阳性,其中7例接受了手术。6例患者的超声检查结果与手术结果完全相符。其余1例患者未发现可识别的腺瘤,但在动脉结扎后PTH恢复正常。所有患者均采用有限的定向手术方法,其中3例采用颈丛阻滞麻醉。4例患者在手术当天出院,所有患者均治愈。US FNA有1例感染并发症。
快速PTH检测可有效地用于补救性甲状旁腺手术中甲状旁腺组织的定位。定位的确认显著改善了后续手术,并允许选择性地使用微创技术。